Aim To assess ten-year risk of diabetes mellitus type 2 (T2DM) using the Finnish Diabetes Risk Score (FINDRISC) in respondents over 18, in Primary Health Centre in Banja Luka. Methods A prospective study was conducted using data from a population with undiagnosed T2DM in Primary Health Centre in Banja Luka. Eligible respondents were those aged 18 to 70 years. Sociodemographic, behavioural and anthropometric variables were those related to the risk models evaluated by FINDRISC. Results Data were collected from 520 individuals, 58.8% female and 41.2% male (p=0.005). A very high risk of developing T2DM in the next ten years was found in 5.6% females and 3.7% males. A high risk was found in 12.4% females and 15.9% males, 34.2% respondents ≥ 65 years, 28.8% with body mass index >30 kg/m 2 , 26.6% who were not practicing physical activity (p=0.000), 24.0% who took antihypertensive drugs, 42.3% who were diagnosed with impaired glycaemia, 30.4% and 22.9% respondents whose parents and distant relatives, respectively, had T2DM. A moderate risk occurred in 31.4% females with waist circumference >88 cm. Half (50%) males with waist circumference >102 cm and 33.2% respondents who were not eating fruits and vegetables every day had a slightly increased risk of developing T2DM (p<0.05). Conclusion The FINDRISC may be used as a tool which would help general practitioners in everyday work, to detect patients with T2DM risk factors and to encourage them to change life style towards healthy habits.
Kuzmanović R, Mirjanić D, Danelišen D, Vulić D, Šošić M, Vuković M. Dijabetes mellitus: Savremena dostignuća i izazovi (Diabetes mellitus: Contemporary Achievements and Challenges). 2017.
2.
Savić S. Banja Luka: Medicinski fakultet Univerziteta u Banjoj Luci (Faculty of Me-dicine. 2019. p. 165–83.
3.
International Diabetes Federation. 2017.
4.
Gbd. Causes of Death Collaborators. Global regional and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study. Lancet. 2016. p. 1151–210.
5.
Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular disease. Chronic kidney disease. and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol. 2014. p. 634–47.
6.
Ncd-Risc ). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016. p. 1513–30.
7.
International Diabetes Federation. IDF Diabetes Atlas. 8th edition. 2017.
8.
Šiljak S, Štrikić D, Lj J, Bratić R, Danojević D, Rudić G, et al. Arsenović S. Analysis of Population Health in Republic of Srpska. Public Health Institute, Republic of Srpska; 2014.
9.
Šiljak S, Štrikić D, Lj J, Bratić R, Danojević D, Rudić G, et al. Arsenović S. Analysis of Population Health in Republic of Srpska. Public Health Institute, Republic of Srpska; 2016.
10.
Who. Diabetes country profiles. 2016.
11.
Savić S, Stanetić K, Račić M, Petrović V, Jatić Z, Savić S, et al. Narodna i univerzitetska biblioteka Republike Srpske. Udruženje doktora porodične medicine Republike Srpske. p. 77–98.
12.
Selph S, Dana T, Blazina I, Bougatsos C, Patel H, Chou R. Screening for type 2 diabetes mellitus: A systematic review for the US. Preventive Services Task Force. Ann Intern Med. 2015. p. 765–76.
13.
Standards of Medical Care in Diabetes-2018. American Diabetes Association;
14.
Lifestyle Management. Diabetes Care. 2018.
15.
Brown N, Critchley J, Bogowicz P, Mayige M, Unwin N. Risk scores based on self-reported or available clinical data to detect undiagnosed type 2 diabetes: a systematic review. Diabetes Res Clin Pract. 2012. p. 369–85.
16.
Khunti K, Mani H, Achana F, Cooper N, Gray L, Davies M. Systematic review and meta-analysis of response rates and diagnostic yield of screening for type 2 diabetes and those at high risk of diabetes. PloS One. 2015. p. 135702.
17.
Lindstrom J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 2003. p. 725–31.
18.
Schwarz P, Li J, Lindstrom J, Tuomilehto J. Tools for predicting the risk of type 2 diabetes in daily practice. Horm Metab Res. 2009. p. 86–97.
19.
Saaristo T, Peltonen M, Lindstrom J, Saarikoski L, Sundvall J, Eriksson J, et al. Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes. Abnormal glucose tolerance and metabolic syndrome. DiabVasc Dis Res. 2005. p. 67–72.
20.
Schwarz P, Li J, Reimann M, Schutte A, Bergmann A, Hanefeld M, et al. The Finnish Diabetes Risk Score is associated with insulin resistance and progression towards type 2 diabetes. J Clin Endocrinol Metab. 2009. p. 920–6.
21.
Zhang L, Zhang Z, Zhang Y, Hu G, Chen L. Evaluation of Finnish Diabetes Risk Score in screening undiagnosed diabetes and prediabetes among US adults by gender and race: NHANES 1999-2010. PloS One. 2014. p. 97865.
22.
Jølle A, Midthjell K, Holmen J, Carlsen M, Tuomilehto S, J, et al. Validity of the FINDRISC as a prediction tool for diabetes in a contemporary Norwegian population: a 10-year follow-up of the HUNT study. BMJ Open Diabetes Research and Care. 2019. p. 769.
23.
Atayoglu A, Inanc N, Başmisirli E, Çapar A. Evaluation of the Finnish Diabetes Risk Score (FIND-RISC) for diabetes screening in Kayseri. Turkey. Prim Care Diabetes. 2020. p. 30514–5.
24.
Perelb P, Miranda J, Smeeth L. Diagnostic accuracy of the Finnish Diabetes Risk Score (FINDRISC) for undiagnosed T2DM in Peruvian population. Primary Care Diabetes. 2018. p. 517–25.
25.
Vandersmissen G, Godderis L. Evaluation of the Finnish Diabetes Risk Score (FINDRISC) for diabetes screening in occupational health care. Int J Occup Med Environ Health. 2015. p. 587–91.
26.
Bergmann A Li J, Wang L, Schulze J, Bornstein S, Schwarz P. A simplified Finnish diabetes risk score to predict type 2 diabetes risk and disease evolution in a German population. Horm Metab Res. 2007. p. 677–82.
27.
Meijnikman A, Block D, Verrijken C, Mertens A, Corthouts I, B, et al. Screening for type 2 diabetes mellitus in overweight and obese subjects made easy by the FINDRISC Score. J Diabetes Complications. 2016. p. 30131–3.
28.
Grujić R, Grabež V, Petković M, Novaković V, Prtina B, A. Abstract book Treći međunarodni kongres Ekologija zdravlje rad sport. Banja Luka. Udruženje ''Zdravlje za sve" (Associations ’ ’Health for all. 2009. p. 170–3.
29.
Diego G, Laura A, Miguel A, Leonardo F, Paul A, Patricio L. Evaluation of the Finnish Diabetes Risk Score to predict type 2 diabetes mellitus in a Colombian population: A longitudinal observational study. Journal ListWorld J Diabetes. 2015. p. 1337–44.
30.
Costa B, Barrio F, Cabré J, Piñol J, Cos X, Solé C, et al. Delaying progression to type 2 diabetes among high-risk Spanish individuals is feasible in real-life primary healthcare settings using intensive lifestyle intervention. Diabetologia. 2012. p. 1319–28.
31.
Kolb H, Martin S. Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes. BMC Med. 2017. p. 131.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
